Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.0 EUR
1.44 B EUR
12.90 B EUR
1.47 B
About Boston Scientific Corporation
Sector
Industry
CEO
Michael F. Mahoney
Website
Headquarters
Marlborough
Founded
1979
FIGI
BBG00PKLKB35
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
BSX4801034
Boston Scientific Corporation 4.7% 01-MAR-2049Yield to maturity
5.57%
Maturity date
Mar 1, 2049
BSX4801033
Boston Scientific Corporation 4.55% 01-MAR-2039Yield to maturity
5.41%
Maturity date
Mar 1, 2039
BSX.GJ
Boston Scientific Corporation 7.375% 15-JAN-2040Yield to maturity
5.26%
Maturity date
Jan 15, 2040
BSX4988126
Boston Scientific Corporation 2.65% 01-JUN-2030Yield to maturity
5.08%
Maturity date
Jun 1, 2030
BSX4800733
Boston Scientific Corporation 4.0% 01-MAR-2029Yield to maturity
4.88%
Maturity date
Mar 1, 2029
BSX4602368
Boston Scientific Corporation 4.0% 01-MAR-2028Yield to maturity
4.86%
Maturity date
Mar 1, 2028
BSX4800732
Boston Scientific Corporation 3.75% 01-MAR-2026Yield to maturity
4.78%
Maturity date
Mar 1, 2026
BSX4988125
Boston Scientific Corporation 1.9% 01-JUN-2025Yield to maturity
4.71%
Maturity date
Jun 1, 2025
CH0A
AMERICAN MEDICAL SYSTEMS EUROPE B.V. 2022-08.03.34 GUARANTEEDYield to maturity
3.45%
Maturity date
Mar 8, 2034
Explore more bonds
Frequently Asked Questions
The current price of BSXC is 86.0 EUR — it has decreased by −1.71% in the past 24 hours. Watch BOSTON SCIENTIFIC CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange BOSTON SCIENTIFIC CORP stocks are traded under the ticker BSXC.
BSXC stock has risen by 4.24% compared to the previous week, the month change is a 4.24% rise, over the last year BOSTON SCIENTIFIC CORP has showed a 69.16% increase.
We've gathered analysts' opinions on BOSTON SCIENTIFIC CORP future price: according to them, BSXC price has a max estimate of 104.15 EUR and a min estimate of 81.43 EUR. Watch BSXC chart and read a more detailed BOSTON SCIENTIFIC CORP stock forecast: see what analysts think of BOSTON SCIENTIFIC CORP and suggest that you do with its stocks.
BSXC reached its all-time high on Nov 22, 2024 with the price of 88.5 EUR, and its all-time low was 23.0 EUR and was reached on Mar 23, 2020. View more price dynamics on BSXC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BSXC stock is 2.91% volatile and has beta coefficient of 0.76. Track BOSTON SCIENTIFIC CORP stock price on the chart and check out the list of the most volatile stocks — is BOSTON SCIENTIFIC CORP there?
Today BOSTON SCIENTIFIC CORP has the market capitalization of 126.65 B, it has increased by 5.85% over the last week.
Yes, you can track BOSTON SCIENTIFIC CORP financials in yearly and quarterly reports right on TradingView.
BOSTON SCIENTIFIC CORP is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
BSXC earnings for the last quarter are 0.57 EUR per share, whereas the estimation was 0.53 EUR resulting in a 7.08% surprise. The estimated earnings for the next quarter are 0.62 EUR per share. See more details about BOSTON SCIENTIFIC CORP earnings.
BOSTON SCIENTIFIC CORP revenue for the last quarter amounts to 3.78 B EUR, despite the estimated figure of 3.63 B EUR. In the next quarter, revenue is expected to reach 4.20 B EUR.
BSXC net income for the last quarter is 421.23 M EUR, while the quarter before that showed 302.49 M EUR of net income which accounts for 39.26% change. Track more BOSTON SCIENTIFIC CORP financial stats to get the full picture.
No, BSXC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 48.00 K employees. See our rating of the largest employees — is BOSTON SCIENTIFIC CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BOSTON SCIENTIFIC CORP EBITDA is 3.47 B EUR, and current EBITDA margin is 23.71%. See more stats in BOSTON SCIENTIFIC CORP financial statements.
Like other stocks, BSXC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BOSTON SCIENTIFIC CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BOSTON SCIENTIFIC CORP technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BOSTON SCIENTIFIC CORP stock shows the buy signal. See more of BOSTON SCIENTIFIC CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.